Lysergic acid methyl ester
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Fswitzer4 (talk | contribs) at 13:14, 27 May 2020 (Added FDA UNII). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
 | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Lysergic acid methyl ester" – news · newspapers · books · scholar · JSTOR (March 2009) (Learn how and when to remove this message) |
| |
| Names | |
|---|---|
| IUPAC name
7-Methyl- 4,6,6a,7,8,9- hexahydro- indolo [4,3-fg] quinoline- 9- carboxylic acid methyl ester
| |
| Other names
Methyl lysergate
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChemSpider |
|
| ECHA InfoCard | 100.022.696 
|
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C17H18N2O2 | |
| Molar mass | 282.343 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Chemical compound
Lysergic acid methyl ester is an analogue of lysergic acid diethylamide (LSD). It is a member of the tryptamine family and is extremely uncommon. It acts on the 5-HT receptors in the brain, as do most tryptamines.
References
External links
- Preparation of lysergic acid esters
- Process for the preparation of lysergic acid esters - Patent 4524208
Hidden categories: